Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 2
2017 6
2018 9
2019 4
2020 9
2021 11
2022 9
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms.
Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, Lau KS, Cowbrough B, Radford K, Huang C, Kjarsgaard M, Dvorkin-Gheva A, Smith J, Li QZ, Waserman S, Ryerson CJ, Nair P, Ho T, Balakrishnan N, Nazy I, Bowdish DME, Svenningsen S, Carlsten C, Mukherjee M. Son K, et al. Among authors: mukherjee m. Eur Respir J. 2023 Jan 12;61(1):2200970. doi: 10.1183/13993003.00970-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36137590 Free PMC article.
Eosinophilic mucus diseases.
Arima M, Ito K, Abe T, Oguma T, Asano K, Mukherjee M, Ueki S. Arima M, et al. Among authors: mukherjee m. Allergol Int. 2024 Apr 8:S1323-8930(24)00040-6. doi: 10.1016/j.alit.2024.03.002. Online ahead of print. Allergol Int. 2024. PMID: 38594175 Free article. Review.
Autoimmune Responses in Severe Asthma.
Mukherjee M, Nair P. Mukherjee M, et al. Allergy Asthma Immunol Res. 2018 Sep;10(5):428-447. doi: 10.4168/aair.2018.10.5.428. Allergy Asthma Immunol Res. 2018. PMID: 30088364 Free PMC article. Review.
Effect of dupilumab on sputum eosinophils in patients with moderate-to-severe asthma.
Svenningsen S, Kjarsgaard M, Zhang K, Serajeddini H, Garrido CV, Bhalla A, Radford K, Huang C, Ho T, Ragunayakam N, Thakar A, Radadia N, Mukherjee M, Nair P. Svenningsen S, et al. Among authors: mukherjee m. Allergy. 2024 Feb;79(2):509-513. doi: 10.1111/all.15901. Epub 2023 Sep 26. Allergy. 2024. PMID: 37750593 No abstract available.
Glucocortiosteroid subsensitivity and asthma severity.
Mukherjee M, Svenningsen S, Nair P. Mukherjee M, et al. Curr Opin Pulm Med. 2017 Jan;23(1):78-88. doi: 10.1097/MCP.0000000000000337. Curr Opin Pulm Med. 2017. PMID: 27801710 Review.
Benralizumab Normalizes Sputum Eosinophilia in Severe Asthma Uncontrolled by Anti-IL-5 Antibodies: A Single-Blind, Placebo-controlled Clinical Trial.
Mukherjee M, Huang C, Venegas-Garrido C, Zhang K, Bhalla A, Ju X, O'Byrne PM, Svenningsen S, Sehmi R, Nair P. Mukherjee M, et al. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1330-1335. doi: 10.1164/rccm.202308-1413LE. Am J Respir Crit Care Med. 2023. PMID: 37824744 Clinical Trial. No abstract available.
60 results